Ashley N. Nilson

Also affiliated with National Institute of Neurological Disorders and Stroke

Biochemistry, Genetics and Molecular BiologyNeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder”.

Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00734

N/A

0.407DataRank · unranked

10 citations

Ashley N. Nilson, Rebekah Placide, Mimi L. Pham, Franziska M. Jakobs, Noelia Boldizsar +30 more

Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics

ChemRxiv(2025)10.26434/chemrxiv-2024-0z6jk-v2

N/A

0.104DataRank · unranked

1 citations

Franziska M. Jacobs, John Hanson, Ashley N. Nilson, Amy E. Moritz, Tian Li +20 more

Identification and Characterization of ML321: a Novel and Highly Selective D 2 Dopamine Receptor Antagonist with Efficacy in Animal Models that Predict Atypical Antipsychotic Activity

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.14.516475

N/A

0DataRank · unranked

0 citations

Ashley N. Nilson, Noelia Boldizsar, Trevor Doyle, Ramona M. Rodriguiz, Vladimir M. Pogorelov +14 more

Identification and Characterization of ML321: A Novel and Highly Selective D 2 Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity

ACS Pharmacology & Translational Science(2022)10.1021/acsptsci.2c00202

N/A

0DataRank · unranked

5 citations

Ashley N. Nilson, Noelia Boldizsar, Trevor Doyle, Ramona M. Rodriguiz, Vladimir M. Pogorelov +14 more

Bioisosteric Replacement of Amides Linkers with 1, 2, 3-Triazoles for Improved Pharmacokinetics Without Losing Dopamine D4 Receptor Potency or Selectivity

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.122.261980

N/A

0DataRank · unranked

0 citations

Mohammad Alkhatib, Julianna Saez, J. B. Hanson, Ashley N. Nilson, Franziska M. Jacobs +10 more

Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics

ChemRxiv(2024)10.26434/chemrxiv-2024-0z6jk

N/A

0DataRank · unranked

0 citations

Franziska M. Jacobs, John Hanson, Ashley N. Nilson, Li Tian, Afua B. Faibille +19 more

Dopamine receptor divergence revealed using a common ligand

Trends in Pharmacological Sciences(2023)10.1016/j.tips.2023.08.002

N/A

0DataRank · unranked

3 citations

Ashley N. Nilson, Amy E. Moritz, Lei Shi, David R. Sibley

Novel Dopamine D4 Receptor‐Selective Antagonists For Neuropsychiatric Disorders

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r5298

N/A

0DataRank · unranked

0 citations

Shreya Kelshikar, Nisha K. Shah, Connor McBride, Moises Ximello Sanchez, Diandra Panasis +11 more